Precision medicine revolutionizes cancer care, empowering patients with personalized insights and targeted therapies while addressing implementation challenges in community oncology.
Jason Hammonds
Advertisement
Jason Hammonds is the chief operating officer of oncology and specialty at McKesson.
Articles by Jason Hammonds
Advertisement
Latest Updated Articles
Expanding Precision Medicine’s Impact on All Tumor TypesPublished: August 9th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
